Showing results (331-340 of 383) with videos related to

Sort By:
Pageof 39
The Annals of Thoracic Surgery|December 1, 1984
The feasibility of adjuvant surgery in limited-stage small cell carcinoma: a prospective evaluationR L Prager, J M Foster, J D Hainsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamideM P Goren, L B Anthony, K R Hande, et al.
Nature Genetics|December 2, 2000
Dominant modifier DFNM1 suppresses recessive deafness DFNB26S Riazuddin, C M Castelein, Z M Ahmed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapyT M Waits, F A Greco, J P Greer, et al.
Investigational New Drugs|April 9, 2001
A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignanciesC D Blanke, M Stipanov, J Morrow, et al.
Science (New York, N.Y.)|June 20, 1998
Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgeneF J Probst, R A Fridell, Y Raphael, et al.
Ophthalmology|November 18, 1998
The probability of blindness from open-angle glaucomaM G Hattenhauer, D H Johnson, H H Ing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering resultsO S Breathnach, B Freidlin, B Conley, et al.
Clinical Lung Cancer|January 22, 2004
Docetaxel and cisplatin in patients with advanced non small-cell lung cancer (NSCLC): a multicenter phase II trialC P Belani, P Bonomi, T W Dobbs, et al.
Pageof 39